Wolters Kluwer and Ecaresoft join forces to deliver integrated healthcare solutions across the Middle East

Together the solutions will help to reduce medication errors and improve patient safety

  

Wolters Kluwer, Health today announced a collaboration with Ecaresoft that will combine the leading drug screening solution Medi-Span® Clinical with Cirrus electronic health record (EHR) and Revenue Cycle Management (RCM) solutions to offer a fully integrated NPHIES compliant solution to healthcare providers.

The move will enable both companies to deliver on a shared global mission to ensure that everyone has access to the best care possible by offering best-in class technologies to healthcare providers in the region.

Medi-Span Clinical is used by hospitals and healthcare systems in 30 countries to screen patient data against drug information within the EHR, alerting clinicians of patient safety risks from allergies, drug interactions, and potentially inappropriate dosing.

Ecaresoft software helps hospitals, clinics and payers drive down costs and operate in more efficient ways by improving communication and making data available to decision makers.

“Working with Ecaresoft reflects our commitment to measurably improving clinical effectiveness by helping healthcare providers across the region deliver optimal care to their patients.” said Christian Cella, vice president of Medi-Span Clinical, Wolters Kluwer, Health.

Alaa Darwish, Country Manager Middle East, Turkey and Africa, Clinical Effectiveness, Wolters Kluwer, Health added, “With both organisations joining forces to help providers deliver best in class care to patients, we are rising to the challenge of improving care quality and clinical outcomes to populations across the region.”

“We are delighted to be working with Wolters Kluwer to provide a cohesive platform that will provide our customers with a greater degree of clinical decision support to enhance patient care and safety.” said Adrian Pina Co-CEO, Ecaresoft.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases